A rare case of NUT midline carcinoma

Gynecologic Oncology Reports

Volumn 3, Issue , 2013, Pages 1-3

  Ball, Allison ^a   Bromley, Amy ^b   Glaze, Sarah ^a   French, Christopher A ^c   Ghatage, Prafull ^a   Köbel, Martin ^b  

^a TOM BAKER CANCER CENTRE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cancer; NMC; NUT midline carcinoma; Thoracic mass

Indexed keywords

EID: 84867946184     PISSN: None     EISSN: 2211338X     Source Type: Journal    
DOI: 10.1016/j.gynor.2012.09.004     Document Type: Article

References (7)

1. Bauer D.E., Mitchell C.M., Strait K.M., Lathan C.S., Stelow E.B., Lüer S.C., et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin. Cancer Res. 2012, (Sep 17. [Epub ahead of print]).
2. French C.A. Pathogenesis of NUT midline carcinoma. Annu. Rev. Pathol. 2012, 7:247-265.
3. French C.A., Miyoshi I., Kubonishi I., Grier H.E., Perez-Atayde A.R., Fletcher J.A. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003, 63:304-307.
4. French C.A., Kutok J.L., Faquin W.C., Toretsky J.A., Antonescu C.R., Griffin C.A., et al. Midline carcinoma of children and young adults with NUT rearrangement. J. Clin. Oncol. 2004, 22:4135-4139.
5. French C.A., Ramirez C.L., Kolmakova J., Hickman T.T., Cameron M.J., Kutok J.L., et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 2008, 27:2237-2242.
6. Haack H., Johnson L.A., Fry C.J., Crosby K., Polakiewicz R.D., Stelow E.B., et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am. J. Surg. Pathol. 2009, 33:984-991.
7. Schwartz B.E., Hofer M.D., Lemieux M.E., Bauer D.E., Cameron M.J., West N.H., et al. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res. 2011, 71:2686-2696.